Cargando…

Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, clinicians have been overwhelmed by questions beyond the SARS-CoV-2 infection itself. In dermatology practice, clinicians have been facing difficulties concerning therapeutic management of chronic immune-mediated skin disease,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campanati, Anna, Diotallevi, Federico, Martina, Emanuela, Radi, Giulia, Offidani, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101352/ https://www.ncbi.nlm.nih.gov/pubmed/35566548 http://dx.doi.org/10.3390/jcm11092422

Ejemplares similares

Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption
por: Campanati, Anna, et al.
Publicado: (2019)

Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
por: Campanati, Anna, et al.
Publicado: (2021)

Mesenchymal Stem Cells and Psoriasis: Systematic Review
por: Diotallevi, Federico, et al.
Publicado: (2022)

Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
por: Martina, Emanuela, et al.
Publicado: (2021)

Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy
por: Diotallevi, Federico, et al.
Publicado: (2021)

Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review
por: Campanati, Anna, et al.
Publicado: (2023)

Saliva and Oral Diseases
por: Martina, Emanuela, et al.
Publicado: (2020)

Latest combination therapies in psoriasis: Narrative review of the literature
por: Diotallevi, Federico, et al.
Publicado: (2022)

New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
por: Matteo, Paolinelli, et al.
Publicado: (2022)

Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult Patients
por: Radi, Giulia, et al.
Publicado: (2021)

Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives
por: Diotallevi, Federico, et al.
Publicado: (2022)

Should we be concerned about gastrointestinal‐related adverse events in patients with plaque psoriasis receiving secukinumab therapy? A retrospective, real‐life study
por: Diotallevi, Federico, et al.
Publicado: (2022)

A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside
por: Radi, Giulia, et al.
Publicado: (2022)

Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study
por: Campanati, Anna, et al.
Publicado: (2022)

Saliva Proteomics as Fluid Signature of Inflammatory and Immune-Mediated Skin Diseases
por: Campanati, Anna, et al.
Publicado: (2021)

Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic
por: Esposito, Maria, et al.
Publicado: (2022)

The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review
por: Diotallevi, Federico, et al.
Publicado: (2022)

Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature
por: Campanati, Anna, et al.
Publicado: (2022)

The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are Going
por: Campanati, Anna, et al.
Publicado: (2022)

Fluorescence‐guided surgery for non‐melanoma and melanoma skin cancer: Case series and a brief review of the literature
por: Ivan, Bobyr, et al.
Publicado: (2021)

Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting
por: Simonetti, Oriana, et al.
Publicado: (2021)

miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review
por: Di Vincenzo, Mariangela, et al.
Publicado: (2023)

InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study
por: Diotallevi, Federico, et al.
Publicado: (2023)

The effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasis
por: Campanati, Anna, et al.
Publicado: (2016)

Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives
por: Campanati, Anna, et al.
Publicado: (2017)

Skin, Autoimmunity and Inflammation: A Comprehensive Exploration through Scientific Research
por: Diotallevi, Federico, et al.
Publicado: (2023)

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis
por: Ganzetti, Giulia, et al.
Publicado: (2016)

Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
por: Fargnoli, Maria Concetta, et al.
Publicado: (2023)

Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review
por: Marani, Andrea, et al.
Publicado: (2022)

Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

The CANOVA Study Real-World Evidence of Biologic Treatments in Moderate-Severe Psoriasis in Italy: A Gender Perspective
por: Colombo, Delia, et al.
Publicado: (2022)

Reticulated acanthoma with sebaceous differentiation
por: Molinelli, Elisa, et al.
Publicado: (2021)

Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations
por: Gisondi, Paolo, et al.
Publicado: (2021)

Sneddon-Wilkinson Disease and Monoclonal Gammopathy of Undetermined Significance in the Elderly: Case Report
por: Ceccarelli, Gabriele, et al.
Publicado: (2019)

Therapy of moderate and severe psoriasis
por: Claes, Christa, et al.
Publicado: (2006)

Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series
por: Bobyr, Ivan, et al.
Publicado: (2016)

Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
por: Molinelli, Elisa, et al.
Publicado: (2020)

Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study
por: TALAMONTI, Marina, et al.
Publicado: (2021)

The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review
por: Tsiogka, Aikaterini, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pot4gmetmqbdo3ghv2qg1s4np9